About MS-Omics
MS-Omics is a company based in Vedbæk (Denmark) founded in 2014 by Lea Girotz Johnsen and Morten Danielsen was acquired by Clinical Microbiomics in October 2022. The company has 2 employees as of July 31, 2023. MS-Omics offers products and services including Metabolomics Services, Data Analysis Services, and Microbiome Applications. MS-Omics operates in a competitive market with competitors including Trace Genomics, Kallyope, AnimalBiome, Clinical Microbiomics and Phylagen, among others.
- Headquarter Vedbæk, Denmark
- Employees 2 as on 31 Jul, 2023
- Founders Lea Girotz Johnsen, Morten Danielsen
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Ms Inc. Dk Aps
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
2
as on Jul 31, 2023
-
Acquired by
Clinical Microbiomics
(Oct 17, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of MS-Omics
MS-Omics offers a comprehensive portfolio of products and services, including Metabolomics Services, Data Analysis Services, and Microbiome Applications.
Provides LC-MS/MS analysis for polar metabolites and research support.
Offers advanced data handling for metabolomics studies and applications.
Delivers analysis for microbiome and clinical research needs.
Funding Insights of MS-Omics
Detailed funding history for MS-Omics
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in MS-Omics
MS-Omics has secured backing from 1 investor. Prominent investors backing the company include Clinical Microbiomics.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Meta-genomics platforms and services for microbiome studies are provided.
|
Locked | Locked | Locked |
Investor details for MS-Omics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by MS-Omics
Investment portfolio details for MS-Omics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - MS-Omics
Detailed financials for MS-Omics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ms-Omics Comparisons
Peer comparison for MS-Omics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of MS-Omics
MS-Omics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Trace Genomics, Kallyope, AnimalBiome, Clinical Microbiomics and Phylagen, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of technologies to diagnose soil health and soil-borne disease prediction
|
|
| Locked | Locked | Locked |
The gut-brain axis is explored for therapeutic and nutritional innovations.
|
|
| Locked | Locked | Locked |
Animal microbiome diagnostics services for pet care are offered.
|
|
| Locked | Locked | Locked |
Meta-genomics platforms and services for microbiome studies are provided.
|
|
| Locked | Locked | Locked |
Delivers comprehensive genome sequencing solutions for microbial analysis.
|
|
| Locked | Locked | Locked |
Next-generation sequencing technologies for microorganism detection are developed.
|
Detailed competitors of MS-Omics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ms-Omics
Complete news archive for MS-Omics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MS-Omics
MS-Omics was founded in 2014.
MS-Omics is headquartered in Vedbæk, Denmark.
As of Jul 31, 2023, the latest employee count at MS-Omics is 2.
MS-Omics was established in 2014 in Vedbaek, Denmark, within the analytical chemistry and biotechnology sector. A specialized platform for metabolomics and data analysis is maintained, alongside services and collaborations focused on advanced data handling. Operations support applications in microbiome studies, clinical research, bacterial analysis, nutrition, and fermentation processes, serving research and industrial needs across these fields.
MS-Omics's top competitors include Trace Genomics, Kallyope and AnimalBiome.
MS-Omics offers Metabolomics Services, Data Analysis Services, and Microbiome Applications.
MS-Omics has 1 investor. Key investors include Clinical Microbiomics.